Arylclobutene-containing multi-functional monomers are useful in the preparation of arylcyclobutene-based polymer coatings. Compositions comprising one or more arylclobutene-containing multi-functional monomers and one or more oligomers comprising as polymerized units one or more arylcyclobutene monomer provide arylcyclobutene-based polymer coatings having reduced stress. Such compositions are useful in the manufacture of electronic devices.

A compound of formula (1a), (1b) or (1c) wherein: n is 1 or 2; R.sup.N is H or Me; R.sup.1 is optionally one or more halo or methyl groups; R.sup.2a and R.sup.2b are independently selected from the group consisting of: (i) F; (ii) H; (iii) Me; and (iv) CH.sub.2OH; R.sup.2c and R.sup.2d (if present) are independently selected from the group consisting of: (i) F; (ii) H; (iii) Me; and (iv) CH.sub.2OH; R.sup.3a and R.sup.3b are independently selected from H and Me; R.sup.4a is selected from OH, NH.sub.2, C(O)NH.sub.2, and CH.sub.2OH; R.sup.4b is either H or Me; R.sup.5 is either H or Me; A is either (i) optionally substituted phenyl; (ii) optionally substituted naphthyl; or (iii) optionally substituted C.sub.5-12 heteroaryl. ##STR00001##

A method for the preparation of purified ivabradine and salts thereof, a method for the purification of ivabradine and salts thereof, a new reactant used in said methods and the use of said reactant for the preparation of ivabradine.

Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia. ##STR00001##

A polymer compound is provided having constitutional units of formula (1) and formula (2), and a constitutional unit of formula (3) and/or (4): ##STR00001##
wherein Ar.sup.1 to Ar.sup.4, Ar.sup.20, Ar.sup.30 and Ar.sup.40 represent arylene groups or the like; Ar.sup.5 to Ar.sup.7 represent aryl groups or the like; Ar.sup.8 represents (2+p)-valent aromatic hydrocarbon group or the like; Ar.sup.10 represents (2+n)-valent aromatic hydrocarbon group or the like; R.sup.1 represents alkyl group or the like; L.sup.a, L.sup.b, L.sup.g and L.sup.h represent alkylene groups or the like; L.sup.A and L.sup.D represent oxygen atoms or the like; Q.sup.1 represents monovalent crosslinkable group; Q.sup.2 to Q.sup.4 represent monovalent crosslinkable groups or the like; x, y, c, nA and nD represent 0 or 1; p represents integer of 1 or greater; na and ng represent integer of 0 to 3; nb and nh represent integer of 0 to 12; and n represents integer of 1 to 4.

The present invention relates to compound of Formula (I) containing carbon-carbon linker, a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a prodrug, a polymorph, N-oxide, S-oxide, or a carboxylic acid isostere thereof; processes for their preparation; pharmaceutical compositions comprising said compounds; and their use for the treatment of the diseases or disorders mediated by GPR120 receptor.

##STR00001##

Specific benzocyclobutenes serve as intramolecular or intermolecular or both intramolecular or intermolecular crosslinkers. The benzocyclobutenes can be incorporated into polymers post polymerization or can be provided as monomers that participate in homopolymerization or copolymerization with other monomer to create the polymers having benzocyclobutenes that are exploited to carry out the crosslinking. At least some of the benzocyclobutenes taught herein can be used to carry out crosslinking a ambient temperatures.

The present invention relates to novel benzocyclobutane(thio) carboxamides, to processes for preparing these compounds, to compositions comprising these compounds, and to the use thereof as biologically active compounds, especially for control of harmful microorganisms in crop protection and in the protection of materials.

Provided are a compound of Chemical Formula 1, a coating composition including the compound, an organic light emitting device using the coating composition, and a manufacturing method thereof.

##STR00001## wherein all the variables are described herein.

A polymer compound comprising a constitutional unit having a group represented by the formula (1): ##STR00001##
wherein Ring A.sup.1A and Ring R.sup.2A represent an aromatic hydrocarbon ring or a heterocyclic ring and these rings each optionally have a substituent, nA represents an integer of 0 to 5, nB represents an integer of 1 to 5, L.sup.A and L.sup.B represent an alkylene group, a cycloalkylene group, an arylene group, a divalent heterocyclic ring group, a group represented by NR, an oxygen atom or a sulfur atom, and R represents a hydrogen atom, an alkyl group or the like, and Q.sup.1 represents a crosslinkable group.